Tang Capital Management as of June 30, 2026
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 41 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals (AUPH) | 10.1 | $221M | 13M | 16.97 | |
| Spyre Therapeutics Com New (SYRE) | 7.6 | $168M | 1.9M | 88.78 | |
| Mirum Pharmaceuticals (MIRM) | 6.6 | $145M | 1.2M | 117.07 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 6.6 | $145M | 2.3M | 63.95 | |
| Celcuity (CELC) | 6.2 | $138M | 1.3M | 104.62 | |
| Corcept Therapeutics Incorporated (CORT) | 5.9 | $130M | 1.5M | 86.95 | |
| Ptc Therapeutics I (PTCT) | 5.6 | $122M | 1.5M | 81.57 | |
| Lakefront Biotherapeutics Nv Spon Adr | 5.2 | $114M | 3.8M | 29.98 | |
| Capricor Therapeutics Com New (CAPR) | 4.5 | $99M | 4.1M | 24.08 | |
| Tarsus Pharmaceuticals (TARS) | 4.5 | $99M | 1.6M | 62.94 | |
| State Str Spdr S&p 500 Etf T Tr Unit (SPY) | 4.2 | $92M | 123k | 746.77 | |
| Anaptysbio Inc Common (ANAB) | 4.1 | $90M | 1.3M | 67.50 | |
| Immunocore Hldgs Ads (IMCR) | 3.8 | $84M | 2.6M | 31.75 | |
| Compass Pathways Sponsored Ads (CMPS) | 3.2 | $71M | 5.0M | 14.15 | |
| Biosante Pharmaceuticals (ANIP) | 2.7 | $59M | 708k | 82.78 | |
| Biontech Se Sponsored Ads (BNTX) | 2.0 | $44M | 470k | 93.05 | |
| Compass Therapeutics (CMPX) | 1.8 | $39M | 18M | 2.19 | |
| Precigen (PGEN) | 1.7 | $37M | 6.4M | 5.70 | |
| Miragen Therapeutics (VRDN) | 1.5 | $33M | 1.8M | 18.37 | |
| Nuvectis Pharma (NVCT) | 1.3 | $29M | 1.6M | 18.39 | |
| Dianthus Therapeutics (DNTH) | 1.2 | $26M | 265k | 97.48 | |
| Fulcrum Therapeutics (FULC) | 1.1 | $24M | 6.5M | 3.66 | |
| Atea Pharmaceuticals (AVIR) | 1.0 | $22M | 4.8M | 4.65 | |
| Crescent Biopharma (CBIO) | 0.9 | $21M | 1.2M | 18.00 | |
| Nano Dimension Sponsord Ads New (NNDM) | 0.9 | $21M | 14M | 1.45 | |
| Viking Therapeutics (VKTX) | 0.9 | $20M | 500k | 39.01 | |
| Nuvation Bio Com Cl A (NUVB) | 0.9 | $19M | 3.3M | 5.68 | |
| Ideaya Biosciences (IDYA) | 0.8 | $17M | 450k | 37.27 | |
| Gossamer Bio Note 5.000% 6/0 (Principal) | 0.5 | $12M | 18M | 0.64 | |
| Journey Med Corp (DERM) | 0.5 | $11M | 1.6M | 7.08 | |
| Insmed Com Par $.01 (INSM) | 0.5 | $11M | 100k | 106.62 | |
| Stoke Therapeutics (STOK) | 0.4 | $9.8M | 300k | 32.72 | |
| Pliant Therapeutics (PLRX) | 0.3 | $7.0M | 6.1M | 1.14 | |
| Boundless Bio (BOLD) | 0.3 | $6.4M | 2.6M | 2.50 | |
| Pmv Pharmaceuticals (PMVP) | 0.3 | $5.7M | 4.2M | 1.34 | |
| Moderna (MRNA) | 0.2 | $3.5M | 50k | 70.03 | |
| Wave Life Sciences SHS (WVE) | 0.2 | $3.5M | 600k | 5.81 | |
| Heron Therapeutics (HRTX) | 0.1 | $2.7M | 6.3M | 0.43 | |
| Lenz Therapeutics (LENZ) | 0.1 | $2.6M | 451k | 5.68 | |
| Altimmune Com New (ALT) | 0.1 | $2.0M | 666k | 3.04 | |
| Rocket Pharmaceuticals (RCKT) | 0.0 | $342k | 100k | 3.42 |
